Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have earned a consensus rating of “Buy” from the ten analysts that are covering the stock, MarketBeat reports. Ten research analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued ratings on the stock […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) insider Scott Bizily sold 1,750 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $25.45, for a total value of $44,537.50. Following the sale, the insider now directly owns 1,737 shares of the […]
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have been given an average rating of “Buy” by the ten research firms that are presently covering the firm, MarketBeat.com reports. Ten investment analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued ratings on […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has received an average recommendation of “Buy” from the ten analysts that are covering the company, MarketBeat reports. Ten investment analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in the last year […]
4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 2 9% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.